Evotec SE
EVO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001412558
No open-market purchases or sales by Evotec SE insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $9.07M in total; no superinvestor holds it.
Other share classesEVOTF
Q3 2025 vs. Q2 2025
How the institutions holding Evotec SE changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 37 | 37 | 0 |
| Shares | 9.65M | 9.89M | +231.2K (+2.4%) |
| Value | $40.5M | $35.9M | −$4.68M (−11.5%) |
New holders (8)
Institutions that held Evotec SE at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tower Research Capital LLC (TRC) | 15,597 | $56.6K | 0.00% |
| Thrivent Financial for Lutherans | 14,502 | $53.0K | 0.00% |
| Quadrant Capital Group LLC | 4,850 | $17.6K | 0.00% |
| MAI Capital Management | 1,320 | $4.79K | 0.00% |
| Rockefeller Capital Management L.P. | 704 | $2.56K | 0.00% |
| Private Trust Co NA | 564 | $2.05K | 0.00% |
| EverSource Wealth Advisors, LLC | 136 | $494 | 0.00% |
| Farther Finance Advisors, LLC | 10 | $36 | 0.00% |
Sold out (8)
Institutions that held Evotec SE at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Marshall Wace, LLP | 40,310 | $169.3K |
| Commonwealth Equity Services, LLC | 18,250 | $77.0K |
| Wiley Bros.-Aintree Capital, LLC | 10,818 | $45.4K |
| Goldman Sachs Group Inc | 10,054 | $42.2K |
| Raymond James Financial Inc | 2,178 | $9.15K |
| Briaud Financial Planning, Inc | 2,160 | $9.00K |
| CBIZ Investment Advisory Services, LLC | 840 | $3.53K |
| Accent Capital Management, LLC | 200 | $840 |